v3.25.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2023
Cash flows from operating activities:      
Net income $ 1,400,723 $ 1,020,951 $ 897,556
Adjustment to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 198,473 176,870 165,156
Amortization of right-of-use assets 37,338 39,339 32,406
Stock-based compensation costs (note 10) 91,661 80,184 71,142
(Gain) loss attributable to equity method investments, net of dividends received (note 6) (3,644) 1,848 10,138
(Gain) loss on equity investments (note 6) 10,299 4,045 (9,922)
Restructuring expenses (note 17) 0 33,239 9,177
Gain on insurance recoveries 0 0 (20,227)
Changes in operating assets and liabilities:      
Accounts receivable (76,684) (134,278) (106,511)
Inventories (80,165) 172,203 (248,833)
Prepaid expenses, net deferred income taxes and other current assets 82,629 (115,213) (138,125)
Accounts payable, accrued expenses and other 90,958 122,072 31,342
Net cash provided by operating activities 1,751,588 1,401,260 693,299
Cash flows from investing activities:      
Purchases of property, plant and equipment (89,865) (99,460) (119,672)
Patent registration costs (10,777) (15,396) (14,328)
Business acquisitions, net of cash acquired (139,248) (133,464) (1,012,749)
Purchases of investments (note 6) (6,416) (12,765) (32,229)
Proceeds from exits of investments (note 6) 4,628 1,000 3,937
Proceeds / (payments) on maturity of foreign currency contracts 41,633 (9,699) 15,196
Net cash used in investing activities (200,045) (269,784) (1,159,845)
Cash flows from financing activities:      
Proceeds from issuance of common stock, net 74,439 53,094 49,142
Taxes paid related to net share settlement of equity awards (18,077) (8,757) (30,631)
Purchases of treasury stock (300,025) (150,011) 0
Payments of business combination contingent consideration (855) (1,293) (2,361)
Acquisition of consolidated subsidiary (10,855) 0 0
Proceeds from borrowings, net of borrowing costs 0 105,000 1,070,000
Repayment of borrowings (40,000) (835,000) (405,000)
Dividends paid (310,880) (282,320) (258,276)
Net cash (used in) provided by financing activities (606,253) (1,119,287) 422,874
Effect of exchange rate changes on cash 25,799 (1,719) (2,147)
Net increase (decrease) in cash and cash equivalents 971,089 10,470 (45,819)
Cash and cash equivalents at beginning of period 238,361 227,891 273,710
Cash and cash equivalents at end of period 1,209,450 238,361 227,891
Supplemental disclosure of cash flow information:      
Income taxes paid, net of refunds 214,013 278,400 216,866
Interest paid 28,415 45,708 47,379
Fair value of assets acquired, excluding cash 43,534 46,033 359,730
Liabilities assumed (6,279) (7,696) (131,765)
Goodwill on acquisition 101,323 92,191 786,990
Deferred payments 670 (143) 2,542
Fair value of contingent consideration 855 4,372 (2,387)
Cash paid for acquisitions $ 140,103 $ 134,757 $ 1,015,110